This is important as, to our knowledge, there has only been one report on the incidence of MLL1 fusions in solid tumors, and this was reported in prostate cancer (Chowdry et al., 2016) and, until now, most of the information regarding MLL1 translocations has been derived from leukemia patients. Here, KMT2A is linked to prostate carcinoma.